Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ

Journal of Clinical Oncology

Volumn 26, Issue 3, 2008, Pages 386-391

  Solin, Lawrence J ^a   Orel, Susan G ^a   Hwang, Wei Ting ^a   Harris, Eleanor E ^a   Schnall, Mitchell D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IRRADIATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; WOMEN'S HEALTH;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38649099041     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.5448     Document Type: Article

References (53)

1. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
2. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
3. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
4. Schwartz GF, Veronesi U, Clough KB, et al: Proceedings of the consensus conference on breast conservation, April 28 to May, 1, 2005, Milan, Italy. Cancer 107:242-250, 2006
5. Orel SG, Schnall MD: MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13-30, 2001
6. Tillman GF, Orel SG, Schnall MD, et al: Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 20:3413-3423, 2002
7. Tan JE, Orel SG, Schnall MD, et al: Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 22:414-418, 1999
8. Schnall MD, Blume J, Bluemke DA, et al: MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92:32-38, 2005
9. Deurloo EE, Peterse JL, Rutgers EJ, et al: Additional breast lesions in patients eligible for breast-conserving therapy by MRI: Impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer 41:1393-1401, 2005
10. Schelfout K, Van Goethem M, Kersschot E, et al: Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30:501-507, 2004
11. Berg WA, Gutierrez L, NessAiver MS, et al: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830-849, 2004
12. Hata T, Takahashi H, Watanabe K, et al: Magnetic resonance imaging for preoperative evaluation of breast cancer: A comparative study with mammography and ultrasonography. J Am Coll Surg 198:190-197, 2004
13. Sardanelli F, Giuseppetti GM, Panizza P, et al: Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 183:1149-1157, 2004
14. Menell JH, Morris EA, Dershaw DD, et al: Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11:382-390, 2005
15. Fleming ID, Cooper JS, Henson DE, et al (eds): AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven Publishers, 1997, pp 171-180
16. Orel SG, Weinstein SP, Schnall MD, et al: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212:543-549, 1999
17. Lee SG, Orel SG, Woo IJ, et al: MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: Preliminary results. Radiology 226:773-778, 2003
18. Weinstein SP, Orel SG, Heller R, et al: MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176:399-406, 2001
19. Nunes LW, Schnall MD, Orel SG, et al: Breast MR imaging: Interpretation model. Radiology 202:833-841, 1997
20. Nunes LW, Schnall MD, Orel SG: Update of breast MR imaging architectural interpretation model. Radiology 219:484-494, 2001
21. Santiago RJ, Wu L, Harris E, et al: Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast cancer: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 58:233-240, 2004
22. Santiago RJ, Harris EE, Qin L, et al: Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Cancer 103:2447-2454, 2005
23. Vapiwala N, Harris E, Hwang WT, et al: Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: Prognostic significance of reexcision. Cancer J 12:25-32, 2006
24. Fowble B, Solin LJ, Schultz DJ: Conservative surgery and radiation for early breast cancer, in Fowble B, Goodman RL, Glick JH, et al (eds): Breast Cancer Treatment: A Comprehensive Guide to Management. St Louis, MO, Mosby Year Book, 1991, pp 105-149
25. Fowble BL, Solin LJ, Schultz DJ, et al: Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 21:269-277, 1991
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
27. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
28. Kalbfleisch J, Prentice R: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons Inc, 1980, pp 70-141
29. Cox DR: Regression models and life tables. Journal of the Royal Statistical Society Series B 34:187-220, 1972
30. Link CL: Confidence intervals for the survival function using Cox's proportional-hazard model with covariates. Biometrics 40:601-609, 1984
31. Faverly DR, Hendriks JH, Holland R: Breast carcinomas of limited extent: Frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 91:647-659, 2001
32. Holland R, Veling SH, Mravunac M, et al: Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer 56:979-990, 1985
33. Kriege M, Brekelmans CTM, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004
34. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
35. Leach MO, Boggis CRM, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778, 2005
36. Lehman CD, Blume JD, Weatherall P, et al: Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898-1905, 2005
37. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004
38. Lehman CD, Gatsonis C, Kuhl CK, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303, 2007
39. Lehman CD, Blume JD, Thickman D, et al: Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 92:9-15, 2005
40. Liberman L, Morris EA, Kim CM, et al: MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180:333-341, 2003
41. Schelfout K, Van Goethem M, Kersshot E, et al: Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol 14:1209-1216, 2004
42. Kepple J, Layeeque R, Klimberg VS, et al: Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623-627, 2005
43. Morrow M: Magnetic resonance imaging in breast cancer: One step forward, two steps back? JAMA 292:2779-2780, 2004
44. Morrow M: Magnetic resonance imaging in breast cancer: Is seeing always believing? Eur J Cancer 41:1368-1369, 2005
45. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493, 1997
46. Partridge SC, Gibbs JE, Lu Y, et al: MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 184:1774-1781, 2005
47. Partridge SC, Gibbs JE, Lu Y, et al: Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193-1199, 2002
48. Chen C, Orel SG, Schnall MD, et al: Breast conservation treatment for patients presenting with axillary lymphadenopathy from presumed primary breast cancer: The role of breast magnetic resonance imaging for staging. Clin Breast Cancer 3:219-222, 2002
49. Chen C, Orel SG, Harris E, et al: Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy. Clin Breast Cancer 5:72-77, 2004
50. Morris EA, Schwartz LH, Dershaw DD, et al: MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205:437-440, 1997
51. Fischer U, Zachariae O, Baum F, et al: The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14:1725-1731, 2004
52. Turnbull LW, Barker S, Liney GP: Comparative effectiveness of magnetic resonance imaging in breast cancer (COMICE trial). Breast Cancer Res 4:39, 2002 (suppl; abstr)
53. Dodwell D, Horgan K: Locoregional treatment for breast cancer. BMJ 327:1062-1063, 2003